​

Arcturus Therapeutics (ARCT) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Arcturus Therapeutics Revenue Highlights

Latest Revenue (Y)

$82.03M

Latest Revenue (Q)

$17.15M

Main Segment (Y)

Collaboration Revenue

Main Geography (Y)

Foreign Countries

Arcturus Therapeutics Revenue by Period

Arcturus Therapeutics Revenue by Year

DateRevenueChange
2025-12-31$82.03M-40.72%
2024-12-31$138.39M-12.27%
2023-12-31$157.75M-23.33%
2022-12-31$205.75M1564.82%
2021-12-31$12.36M29.56%
2020-12-31$9.54M-54.12%
2019-12-31$20.79M31.97%
2018-12-31$15.75M21.20%
2017-12-31$13.00M-36.23%
2016-12-31$20.38M232.06%
2015-12-31$6.14M100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31-100.00%
2011-12-31--

Arcturus Therapeutics generated $82.03M in revenue during NA 2025, up -40.72% compared to the previous quarter, and up 859.95% compared to the same period a year ago.

Arcturus Therapeutics Revenue by Quarter

DateRevenueChange
2025-09-30$17.15M-30.02%
2025-06-30$24.51M-16.58%
2025-03-31$29.38M39.91%
2024-12-31$21.00M-45.90%
2024-09-30$38.81M-15.58%
2024-06-30$45.98M41.04%
2024-03-31$32.60M29.99%
2023-12-31$25.08M-42.18%
2023-09-30$43.38M312.36%
2023-06-30$10.52M-86.90%
2023-03-31$80.28M-49.91%
2022-12-31$160.29M1098.99%
2022-09-30$13.37M-50.66%
2022-06-30$27.09M416.65%
2022-03-31$5.24M-9.49%
2021-12-31$5.79M137.75%
2021-09-30$2.44M21.79%
2021-06-30$2.00M-5.92%
2021-03-31$2.13M-4.96%
2020-12-31$2.24M-4.07%
2020-09-30$2.33M0.47%
2020-06-30$2.32M-12.24%
2020-03-31$2.65M-10.85%
2019-12-31$2.97M-10.55%
2019-09-30$3.32M-67.32%
2019-06-30$10.15M133.40%
2019-03-31$4.35M-42.59%
2018-12-31$7.58M121.36%
2018-09-30$3.42M43.46%
2018-06-30$2.39M0.80%
2018-03-31$2.37M-81.79%
2017-12-31$13.00M294.36%
2017-09-30$3.30M-12.36%
2017-06-30$3.76M-2.08%
2017-03-31$3.84M100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30--

Arcturus Therapeutics generated $17.15M in revenue during Q3 2025, up -30.02% compared to the previous quarter, and up 37.30% compared to the same period a year ago.

Arcturus Therapeutics Revenue Breakdown

Arcturus Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24Dec 23Dec 22
Grant$14.81M$13.92M--
Collaboration Revenue$67.22M$138.39M$157.75M$205.75M

Arcturus Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 25: Collaboration Revenue (81.95%), and Grant (18.05%).

Quarterly Revenue by Product

Product/ServiceDec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Jun 23Mar 23Jun 19
Collaboration Revenue$3.08M$14.15M$24.51M$25.48M$21.00M$38.81M$45.98M$32.60M$78.02M$79.73M--
Grant$4.12M$3.00M$3.79M$3.90M$1.77M$2.86M$3.88M$5.41M$954.00K$556.00K--
Other Collaboration Revenue-----------$3.60M

Arcturus Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Grant (57.19%), and Collaboration Revenue (42.81%).

Arcturus Therapeutics Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 25Dec 24
Foreign Countries$67.10M$138.40M

Arcturus Therapeutics's latest annual revenue breakdown by geography, as of Dec 25: Foreign Countries (100.00%).

Arcturus Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
VNDAVanda Pharmaceuticals$216.10M$56.26M
ARCTArcturus Therapeutics$82.03M$17.15M
VYGRVoyager Therapeutics$40.37M$13.37M
FHTXFoghorn Therapeutics$30.91M$8.15M
TRDAEntrada Therapeutics$25.42M$1.61M
IMRXImmuneering--
ZURAZura Bio--
HUMAHumacyte-$753.00K
SGMTSagimet Biosciences--
ACHVAchieve Life Sciences--
AVIRAtea Pharmaceuticals--

ARCT Revenue FAQ

What is Arcturus Therapeutics’s yearly revenue?

Arcturus Therapeutics's yearly revenue for 2025 was $82.03M, representing a decrease of -40.72% compared to 2024. The company's yearly revenue for 2024 was $138.39M, representing a decrease of -12.27% compared to 2023. ARCT's yearly revenue for 2023 was $157.75M, representing a decrease of -23.33% compared to 2022.

What is Arcturus Therapeutics’s quarterly revenue?

Arcturus Therapeutics's quarterly revenue for Q3 2025 was $17.15M, a -30.02% decrease from the previous quarter (Q2 2025), and a -55.81% decrease year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $24.51M, a -16.58% decrease from the previous quarter (Q1 2025), and a -46.69% decrease year-over-year (Q2 2024). ARCT's quarterly revenue for Q1 2025 was $29.38M, a 39.91% increase from the previous quarter (Q4 2024), and a -9.87% decrease year-over-year (Q1 2024).

What is Arcturus Therapeutics’s revenue growth rate?

Arcturus Therapeutics's revenue growth rate for the last 3 years (2023-2025) was -48.00%, and for the last 5 years (2021-2025) was 563.73%.

What are Arcturus Therapeutics’s revenue streams?

Arcturus Therapeutics's revenue streams in c 25 are Grant, and Collaboration Revenue. Grant generated $14.81M in revenue, accounting 18.05% of the company's total revenue, up 6.39% year-over-year. Collaboration Revenue generated $67.22M in revenue, accounting 81.95% of the company's total revenue, down -51.43% year-over-year.

What is Arcturus Therapeutics’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Arcturus Therapeutics was Collaboration Revenue. This segment made a revenue of $67.22M, representing 81.95% of the company's total revenue.